Evidence map›Paper›PMID 32489372›Full record

ArticleIranian journal of parasitology

Efficacy and Safety of

Hossein Mahmoudvand, Amir Tavakoli Kareshk, Mohammad Nabi Moradi, Lianet Monzote Fidalgo, Seyed Reza Mirbadie, Massumeh Niazi, Mehrdad Khatami

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Humane Endpoints in Swiss Webster Mice Infected withAnimals : an open access journal from MDPI · 2024
    Article
  4. Review
  5. Potent In Vitro and In Vivo Effects ofTropical medicine and infectious disease · 2023
    Article
  6. Potential effects of alpha-pinene, a monoterpene commonly found in essential oils againstJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  7. Nano amphotericin B: a good anti-leishmanial drug with effect on cathelicidin gene expression.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Protective effect ofAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Hossein MahmoudvandRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Amir Tavakoli KareshkInfectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Mohammad Nabi MoradiDepartment of Laboratory Sciences, School of Allied Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Lianet Monzote FidalgoDepartment of Parasitology, Institute of Tropical Medicine "Pedro Kourí", La Lisa, Havana, Cuba.
Seyed Reza MirbadieSchool of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Massumeh NiaziStudent Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mehrdad KhatamiBam University of Medical Sciences, Bam, Iran.
Lorestan University of Medical Sciences · IRBam University of Medical Sciences · IRBirjand University of Medical Sciences · IRInstituto de Medicina Tropical “Pedro Kourí” · CUShahroud University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBroad spectrums of pharmacological properties, including antimicrobial activity have been attributed to

methods

resultsGC/MS analysis displayed that the key constituents were thymol (45.4%), carvacrol (23%) and

conclusionThe results demonstrated the efficacy of ZM-EO against acute toxoplasmosis. Nevertheless, supplementary surveys are mandatory to examine its precise effects, mainly immunomodulatory effect on toxoplasmosis.

Indexed as

Essential oilHerbal medicinesProphylacticToxicityToxoplasma gondiiTreatment

Identifiers

PMID32489372
PMCPMC7244848
OpenAlexW3011363485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.